Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2013
A phase II trial of gemcitabine, irinotecan and panitumumab in advanced cholangiocarcinomaD P S Sohal, K Mykulowycz, T Uehara, et al.
Cancer|February 14, 2015
Predicting early mortality in resectable pancreatic adenocarcinoma: A cohort studyDavendra P S Sohal, Shiva Shrotriya, Kate Tullio Glass, et al.
JCO Precision Oncology|February 1, 2022
Tissue/Site-Agnostic Study of Ribociclib for Tumors With Cyclin D-CDK4/6 Pathway Genomic Alterations: A Phase II, Open-Label, Single-Arm Basket StudyJulio Peguero, Davendra P S Sohal, Bert H O'Neil, et al.
JCO Precision Oncology|February 9, 2022
Precision Oncology in Solid Tumors: A Longitudinal Tertiary Care Center ExperienceMeena Sadaps, Pauline Funchain, Haider Mahdi, et al.
Annals of Surgery|August 3, 2020
Surgical Outcome Results From SWOG S1505: A Randomized Clinical Trial of mFOLFIRINOX Versus Gemcitabine/Nab-paclitaxel for Perioperative Treatment of Resectable Pancreatic Ductal AdenocarcinomaSyed A Ahmad, Mai Duong, Davendra P S Sohal, et al.
JAMA Oncology|January 21, 2021
Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical TrialDavendra P S Sohal, Mai Duong, Syed A Ahmad, et al.
Cancer Chemotherapy and Pharmacology|March 28, 2013
Toxicity study of gemcitabine, oxaliplatin, and bevacizumab, followed by 5-fluorouracil, oxaliplatin, bevacizumab, and radiotherapy, in patients with locally advanced pancreatic cancerDavendra P S Sohal, James M Metz, Weijing Sun, et al.
Cancer|March 11, 2026
Targeted therapy for DNA damage response and homologous recombination repair defects: The Olaparib Combinations trialDeborah B Doroshow, Geoffrey I Shapiro, Khanh Do, et al.
European Journal of Cancer (Oxford, England : 1990)|February 15, 2021
A first-in-human phase I/Ib dose-escalation clinical trial of the autophagy inducer ABTL0812 in patients with advanced solid tumoursLaura Vidal, Ivan Victoria, Lydia Gaba, et al.
The Lancet. Oncology|March 6, 2020
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trialMichael J Pishvaian, Edik M Blais, Jonathan R Brody, et al.
Pageof 6